19 September 2024 : Clinical Research
Intravenous Lidocaine Response as a Predictor for Oral Oxcarbazepine Efficacy in Neuropathic Pain Syndrome: A Prospective Cohort Study
Sukunya Jirachaipitak1ABCDEF, Pramote Euasobhon1ABCDEFG*, Suthanee Cenpakdee1ABEF, Suratsawadee Wangnamthip1ABDE, Pranee Rushatamukayanunt1ABDEDOI: 10.12659/MSM.945612
Med Sci Monit 2024; 30:e945612
Figure 2 Relation of pain reduction after lidocaine infusion and after oxcarbazepine treatment. There are 21 of 32 patients (a small circle represents 1 patient) who demonstrated a good correlation of pain reduction between i.v. lidocaine infusion and oral oxcarbazepine (OXC) treatment in the range of ±20% (area between 2 orange lines). Figure created using Microsoft Word (Version 2019, Microsoft Corporation).